{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T23:23:00Z","timestamp":1720740180222},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T00:00:00Z","timestamp":1452556800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","respiratorycasereports.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/j.rmcr.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T12:48:55Z","timestamp":1452862135000},"page":"44-46","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immunomodulatory effect of macrolides: At what cost?"],"prefix":"10.1016","volume":"17","author":[{"given":"Maria","family":"Kipourou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Manika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Papavasileiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Pitsiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Lada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Ntinapogias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Kioumis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rmcr.2016.01.004_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmcr.2016.01.004_bib2","doi-asserted-by":"crossref","first-page":"e000050","DOI":"10.1136\/bmjresp-2014-000050","article-title":"Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease","volume":"1","author":"Fujita","year":"2014","journal-title":"BMJ Open Respir. Res."},{"issue":"7","key":"10.1016\/j.rmcr.2016.01.004_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1164\/rccm.201003-0503OC","article-title":"Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease","volume":"182","author":"Winthrop","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.rmcr.2016.01.004_bib4","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1016\/j.ijid.2013.03.018","article-title":"Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis","volume":"17","author":"Mirsaeidi","year":"2013","journal-title":"Int. J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.rmcr.2016.01.004_bib5","doi-asserted-by":"crossref","first-page":"e36902","DOI":"10.1371\/journal.pone.0036902","article-title":"Failure to recognize nontuberculous mycobacteria leads to misdiagnosis of chronic pulmonary tuberculosis","volume":"7","author":"Maiga","year":"2012","journal-title":"PloS one"},{"issue":"13","key":"10.1016\/j.rmcr.2016.01.004_bib6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1056\/NEJM198909283211304","article-title":"Infection with Mycobacterium avium complex in patients without predisposing conditions","volume":"321","author":"Prince","year":"1989","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.rmcr.2016.01.004_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10156-006-0457-8","article-title":"Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates","volume":"12","author":"Kobashi","year":"2006","journal-title":"J.\u00a0Infect. Chemother."},{"issue":"7","key":"10.1016\/j.rmcr.2016.01.004_bib8","first-page":"628","article-title":"Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment","volume":"6","author":"The Research Committee of the British Thoracic Society","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"10","key":"10.1016\/j.rmcr.2016.01.004_bib9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"Flume","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmcr.2016.01.004_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh519","article-title":"Anti-inflammatory effects of macrolides\u2014an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?","volume":"55","author":"Amsden","year":"2005","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"12","key":"10.1016\/j.rmcr.2016.01.004_bib11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non\u2013Cystic Fibrosis Bronchiectasis: The BLESS Randomized Controlled Trial","volume":"309","author":"Serisier","year":"2013","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.rmcr.2016.01.004_bib12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non\u2013cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"Jama"},{"issue":"9560","key":"10.1016\/j.rmcr.2016.01.004_bib13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rmcr.2016.01.004_bib14","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmcr.2016.01.004_bib15","unstructured":"Working Group of Greek Comitee of Infectious Diseases, Greek Chemotherapy Comitee and Greek Comitee of Respiratory Disease. Guidelines for the diagnosis and empirical treatment of community acquired pneumonia. In: Guidelines for Diagnosis and Treatment of Infectious Diseases, Scientific Comitee of Hospital acquired Infectious Diseases."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007116300041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007116300041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T01:20:57Z","timestamp":1537060857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007116300041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":15,"alternative-id":["S2213007116300041"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2016.01.004","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory effect of macrolides: At what cost?","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}